x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
Delaware | 11-1719724 |
(State or Other Jurisdiction of | (I.R.S. Employer Identification No.) |
Incorporation or Organization) |
N/A |
Large accelerated filer
|
o
|
Non-accelerated filer
|
o
(Do not check if a smaller reporting company)
|
Accelerated filer
|
o
|
Smaller reporting company
|
x
|
Page No.
|
|
ITEM
1.
|
Condensed Financial Statements
|
SIX MONTHS ENDED
JUNE 30,
|
THREE MONTHS ENDED
JUNE 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Net sales
|
$ | 7,311,467 | $ | 6,888,287 | $ | 3,734,552 | $ | 2,993,144 | ||||||||
Costs and expenses:
|
||||||||||||||||
Cost of sales
|
2,811,946 | 2,819,916 | 1,397,379 | 1,273,597 | ||||||||||||
Operating expenses
|
1,326,629 | 1,397,382 | 708,580 | 687,397 | ||||||||||||
Pension plan termination
|
847,744 | --- | 847,744 | --- | ||||||||||||
4,986,319 | 4,217,298 | 2,953,703 | 1,960,994 | |||||||||||||
Income from operations
|
2,325,148 | 2,670,989 | 780,849 | 1,032,150 | ||||||||||||
Other income:
|
||||||||||||||||
Investment income
|
225,146 | 185,083 | 132,876 | 93,481 | ||||||||||||
Income from operations before income taxes
|
2,550,294 | 2,856,072 | 913,725 | 1,125,631 | ||||||||||||
Provision for income taxes
|
829,926 | 945,400 | 289,201 | 370,200 | ||||||||||||
Net Income
|
$ | 1,720,368 | $ | 1,910,672 | $ | 624,524 | $ | 755,431 | ||||||||
|
||||||||||||||||
Earnings per common share
(Basic and Diluted)
|
$ | 0.35 | $ | 0.39 | $ | 0.13 | $ | 0.15 | ||||||||
Weighted average shares – basic and diluted
|
4,882,627 | 4,946,439 | 4,819,516 | 4.946,439 |
ASSETS
|
JUNE 30,
|
DECEMBER 31,
|
||||||
2010
|
2009
|
|||||||
Current assets
:
|
(UNAUDITED)
|
|||||||
Cash and cash equivalents
|
$ | 1,368,922 | $ | 5,021,073 | ||||
Certificates of deposit
|
436,467 | 1,014,866 | ||||||
Marketable securities
|
7,364,872 | 8,438,757 | ||||||
Accounts receivable, net of allowance for doubtful
accounts of $27,000 at June 30, 2010 and
December 31, 2009
|
2,020,888 | 1,364,886 | ||||||
Inventories (net)
|
1,317,982 | 1,153,134 | ||||||
Prepaid expenses and other current assets
|
192,841 | 220,815 | ||||||
Deferred income taxes
|
263,393 | 443,034 | ||||||
Total current assets
|
12,965,365 | 17,656,565 | ||||||
Property, plant and equipment
:
|
||||||||
Land
|
69,000 | 69,000 | ||||||
Factory equipment and fixtures
|
3,446,740 | 3,302,967 | ||||||
Building and improvements
|
2,598,244 | 2,541,115 | ||||||
Waste disposal plant
|
133,532 | 133,532 | ||||||
6,247,516 | 6,046,614 | |||||||
Less: Accumulated depreciation
|
5,181,373 | 5,099,903 | ||||||
Total property, plant and equipment, net
|
1,066,143 | 946,711 | ||||||
Other assets
|
137,473 | 113,016 | ||||||
TOTAL ASSETS
|
$ | 14,168,981 | $ | 18,716,292 |
JUNE 30,
|
DECEMBER 31,
|
|||||||
2010
|
2009
|
|||||||
Current liabilities:
|
(UNAUDITED)
|
|
||||||
Dividends payable
|
$ | --- | $ | 1,582,860 | ||||
Accounts payable
|
259,457 | 322,325 | ||||||
Accrued expenses
|
897,455 | 819,194 | ||||||
Pension liability
|
446,270 | 108,892 | ||||||
Income taxes payable
|
35,603 | 87,403 | ||||||
Total current liabilities
|
1,638,785 | 2,920,674 | ||||||
Deferred income taxes
|
18,251 | 138,007 | ||||||
Stockholders’ equity:
|
||||||||
Common stock $.10 par value; 10,000,000 shares
authorized; 4,596,439 and 5,008,639
shares issued, and 4,596,439 and 4,946,439
shares outstanding, at June 30, 2010 and
December 31, 2009, respectively.
|
459,644 | 500,864 | ||||||
Capital in excess of par value
|
--- | 3,819,480 | ||||||
Accumulated other comprehensive income (loss)
|
34,406 | (345,992 | ) | |||||
Retained earnings
|
12,017,895 | 12,042,889 | ||||||
Treasury stock, at cost; 62,200 shares at
December 31, 2009
|
--- | (359,630 | ) | |||||
Total stockholders’ equity
|
12,511,945 | 15,657,611 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS’
EQUITY
|
$ | 14,168,981 | $ | 18,716,292 |
SIX MONTHS ENDED
|
||||||||
June 30,
|
||||||||
2010
|
2009
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$ | 1,720,368 | $ | 1,910,672 | ||||
Adjustments to reconcile net income
to net cash
provided by operating activities:
|
||||||||
Depreciation and amortization
|
108,266 | 85,419 | ||||||
Realized (gain) loss on sales of marketable
securities
|
(47,909 | ) | 498 | |||||
Realized loss on pension termination
|
338,655 | --- | ||||||
Reduction in allowance for bad debts
|
--- | (2,616 | ) | |||||
Increase (decrease) in cash resulting from
changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
(656,002 | ) | 256,740 | |||||
Inventories
|
(164,848 | ) | 167,898 | |||||
Prepaid expenses and other current
and non-current assets
|
||||||||
(15,319 | ) | (107,242 | ) | |||||
Deferred income taxes
|
37,742 | --- | ||||||
Accounts payable
|
(62,868 | ) | (50,746 | ) | ||||
Accrued expenses and taxes payable
|
26,461 | 172,038 | ||||||
Pension liability
|
337,378 | --- | ||||||
Net cash provided by operating activities
|
1,621,924 | 2,432,661 | ||||||
Cash flows from investing activities:
|
||||||||
Acquisition of property, plant and equipment
|
(208,862 | ) | (15,304 | ) | ||||
Proceeds from sale of marketable securities
|
5,104,428 | 300,000 | ||||||
Purchases of marketable securities
|
(3,918,748 | ) | (490,841 | ) | ||||
Net change in certificates of deposit
|
578,399 | (14,376 | ) | |||||
Net cash used in investing
activities
|
(1,555,217 | ) | (220,521 | ) | ||||
|
||||||||
Cash flows from financing activities:
|
||||||||
Acquisition of treasury stock
|
(3,762,500 | ) | --- | |||||
Payment of long term debt
|
--- | (6,657 | ) | |||||
Dividends paid
|
(3,066,792 | ) | (2,770,006 | ) | ||||
Net cash used in financing activities
|
(6,829,292 | ) | (2,776,663 | ) | ||||
Net decrease in cash and cash
equivalents
|
(3,652,151 | ) | (564,523 | ) | ||||
Cash and cash equivalents at beginning of period
|
5,021,073 | 3,425,538 | ||||||
Cash and cash equivalents at end of period
|
$ | 1,368,922 | $ | 2,861,015 |
1.
|
Nature of Business
|
2.
|
Basis of Presentation
|
3.
|
Stock-Based Compensation
|
4.
|
Recent Accounting Pronouncements
|
5.
|
Investments
|
•
|
Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
|
•
|
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
|
•
|
Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.
|
Unrealized
|
||||||||||||
June 30, 2010
|
Cost
|
Fair Value
|
Gain/(Loss)
|
|||||||||
Available for Sale:
|
||||||||||||
U.S. Treasury and agencies
|
||||||||||||
Mature within 1 year
|
$ | 1,145,747 | $ | 1,154,133 | $ | 8,386 | ||||||
Mature after 1 year through 5 years
|
507,126 | 500,628 | (6,498 | ) | ||||||||
Total US Treasury and agencies
|
1,652,873 | 1,654,761 | 1,888 | |||||||||
Corporate bonds
|
||||||||||||
Maturities after 1 year through 5 years
|
267,251 | 259,833 | (7,418 | ) | ||||||||
Fixed income mutual funds
|
5,145,290 | 5,252,633 | 107,343 | |||||||||
Equity and other mutual funds
|
246,801 | 197,645 | (49,156 | ) | ||||||||
$ | 7,312,215 | $ | 7,364,872 | $ | 52,657 |
December 31, 2009
|
Cost
|
Fair Value
|
Unrealized
Gain/(Loss)
|
|||||||||
Available for Sale:
|
||||||||||||
U.S. Treasury and agencies
|
||||||||||||
Mature within 1 year
|
$ | 1,650,218 | $ | 1,659,596 | $ | 9,378 | ||||||
Maturities after 1 year through 5 years
|
1,108,726 | 1,124,527 | 15,801 | |||||||||
Total US Treasury and agencies
|
2,758,944 | 2,784,123 | 25,179 | |||||||||
Corporate bonds
|
||||||||||||
Maturities after 1 year through 5 years
|
267,251 | 262,846 | (4,405 | ) | ||||||||
Fixed income mutual funds
|
5,179,005 | 5,181,990 | 2,985 | |||||||||
Equity and other mutual funds
|
244,786 | 209,798 | (34,988 | ) | ||||||||
$ | 8,449,986 | $ | 8,438,757 | $ | (11,229 | ) |
6
.
|
Inventories - Net
|
June 30, | December 31, | |||||||
2010
|
2009
|
|||||||
Inventories consist of the following:
|
||||||||
Raw materials and work in process
|
$ | 564,029 | $ | 329,562 | ||||
Finished products
|
753,953 | 823,572 | ||||||
$ | 1,317,982 | $ | 1,153,134 |
7.
|
Supplemental Financial Statement Information
|
8.
|
Income Taxes
|
9.
|
Comprehensive Income
|
Six months ended
June 30,
|
Three months ended
June 30
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Net income
|
$ | 1,720,368 | $ | 1,910,672 | $ | 624,524 | $ | 755,431 | ||||||||
Other comprehensive income
|
||||||||||||||||
Unrealized gain on
marketable
securities during period
|
||||||||||||||||
63,886 | 146,777 | 23,724 | 141,705 | |||||||||||||
Adjustment for pension
termination
|
518,296 | --- | 518,296 | --- | ||||||||||||
Income tax (benefit) expense
related to other
comprehensive income
|
||||||||||||||||
(201,784 | ) | 50,873 | (187,864 | ) | 49,115 | |||||||||||
Other comprehensive income,
net of tax
|
||||||||||||||||
380,398 | 95,904 | 354,156 | 92,590 | |||||||||||||
Comprehensive income
|
$ | 2,100,766 | $ | 2,006,576 | $ | 978,680 | $ | 848,021 |
10.
|
Defined Benefit Pension Plan and New Defined Contribution Plan.
|
11.
|
Other Information
|
June 30, | December 31, | |||||||
2010
|
2009
|
|||||||
Accrued bonuses
|
$ | 366,645 | $ | 182,000 | ||||
Accrued distribution fees
|
186,595 | 303,493 | ||||||
Other
|
344,215 | 333,701 | ||||||
$ | 897,455 | $ | 819,194 |
Item
2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
(a)
|
Pharmaceuticals:
Pharmaceutical sales for the six months ended June 30, 2010 decreased $276,026 (16.4%) compared with the same period in 2009, and pharmaceutical sales for the three months ended June 30, 2010 decreased $389,286 (38.4%) when compared with the three months ended June 30, 2009. This was the result of a price increase that was implemented on May 1, 2009, which caused a significant increase in sales in April 2009 as customers purchased additional inventory in anticipation of the price increase. The Company implemented a price increase on April 1, 2010, but the increase in sales prior to the effective date of the 2010 increase was much smaller than it was in 2009. Since the annual unit sales volume of these products is relatively stable from year-to-year, the Company estimates that the dollar value of pharmaceutical sales in calendar 2010 will increase as a result of the price increase that occurred in April 2010.
|
(b)
|
Personal care products
: For the six months ended June 30, 2010, the Company’s sales of personal care products increased by $899,965 (24.7%) when compared with the six months ended June 30, 2009. For the three months ended June 30, 2010, the Company’s sales of personal care products increased by $1,032,348 (77.0%) when compared with the three months ended June 30, 2009. These increases were primarily the result of sales increases in 2010 to the Company’s two largest marketing partners, ISP and Sederma. Sales to ISP increased by $435,422 (15.5%) and $637,837 (61.5%) for the six- and three-month periods,
|
|
respectively, ended June 30, 2010, compared with the comparable periods in 2009. Sales to Sederma increased by $448,374 (164.1%) and $322,763 (571.8%) for the six- and three-month periods, respectively, ended June 30, 2010, compared with the comparable periods in 2009.
|
(c)
|
Medical (non-pharmaceutical) products:
Sales of the Company’s medical products decreased by $412,680 (24.2%) and $94,241 (13.0%) for the six- and three-month periods, respectively, ended June 30, 2010, when compared with the corresponding periods ended June 30, 2009. These changes are primarily due to one of the Company’s customers that concentrated all of its 2009 purchases into the first six months of 2009 prior to moving its production facility in late 2009. That customer's purchases are expected to be made in a more orderly manner over the entire year in 2010, resulting in higher sales of these products in the second half of 2010 when compared with the second half of 2009.
|
Item
3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
.
|
Item
4T.
|
CONTROLS AND PROCEDURES
|
(a)
|
DISCLOSURE CONTROLS AND PROCEDURES
|
(b)
|
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
|
ITEM
1.
|
LEGAL PROCEEDINGS
|
ITEM
1A.
|
RISK FACTORS
|
ITEM
2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
.
|
ITEM
3.
|
DEFAULTS UPON SENIOR SECURITIES
|
ITEM
4.
|
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
ITEM
5.
|
OTHER INFORMATION
|
ITEM
6.
|
EXHIBITS
|
10.1
|
Letter agreement dated May 5, 2010 between the Company and ISP
|
10.2
|
Stock Purchase Agreement dated May 17, 2010 between the Company and Kenneth H. Globus. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated May 17, 2010 and filed with the United States Securities and Exchange Commission on May 18, 2010.
|
31.1
|
Certification of Kenneth H. Globus, President and principal executive officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
Certification of Robert S. Rubinger, Chief Financial Officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
Certification of Kenneth H. Globus, President and principal executive officer of the Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2
|
Certification of Robert S. Rubinger, Chief Financial Officer of the Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
Hwy 146 & Attwater Ave. PO Box 2141 Texas City Tx 77592-2141
|
(409) 945 3411
|
Attention:
|
Mr. Kenneth H. Globus, Esq., President
|
1.
|
I have reviewed this Quarterly Report of United-Guardian, Inc. on Form 10-Q for the three-month period ended June 30, 2010;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
1.
|
I have reviewed this Quarterly Report of United-Guardian, Inc. on Form 10-Q for the three-month period ended June 30, 2010;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|